Previous Close | 0.6750 |
Open | 0.6837 |
Bid | 0.0000 x 800 |
Ask | 0.7500 x 800 |
Day's Range | 0.6598 - 0.7000 |
52 Week Range | 0.0241 - 2.4050 |
Volume | |
Avg. Volume | 1,075,921 |
Market Cap | 24.91M |
Beta (5Y Monthly) | 0.19 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.8300 |
Earnings Date | May 08, 2023 - May 12, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Apr 02, 2020 |
1y Target Est | 1.30 |
Invacare Corporation (NYSE: IVC) entered into a “Restructuring Support Agreement” (RSA) with substantially all its debt holders. It includes its term loan lender, all holders of convertible senior secured notes, and holders of most convertible senior unsecured notes. The RSA transactions include a reduction of Invacare’s funded debt by approximately $240 million. It also includes a backstop for a rights offering to holders of claims, providing Invacare with $60 million in equity capital, allowin
The Elyria, Ohio-based medical equipment maker and distributor has worked out a restructuring support agreement with "substantially all of its debt holders" prior to the bankruptcy filing.
Invacare Corp. (IVC) said Wednesday it and two of its U.S.-based subsidiaries have filed for bankruptcy, as it implements a refinancing aimed at reducing net debt by about 65%. The Ohio-based company, which makes at-home and long-term care medical products used to promote recovery, said it will continue to pay its suppliers, and doesn’t expect the bankruptcy to hurt its ability to make and deliver products.